Literature DB >> 1929206

Antiepileptogenic effects of conventional anticonvulsants in the kindling model of epilespy.

J M Silver1, C Shin, J O McNamara.   

Abstract

We sought to determine whether the clinically effective anticonvulsant drug valproate exhibited antiepileptogenic properties in the kindling model (we use the term anticonvulsant to mean suppression of seizure, and antiepileptogenic to mean suppression of development of epilepsy). We compared and contrasted valproate with two other anticonvulsant drugs, phenobarbital and carbamazepine. We investigated the effects of these drugs on the development of kindling, that is, the number of stimulation-induced afterdischarges required to induce enhanced seizure susceptibility in rats. Valproate exhibited powerful antiepileptogenic effects as evident in a dose-dependent increase in the number of afterdischarges required to induce kindling. These effects were not due to retained valproate or an active metabolite merely masking the expression of kindled seizures. By contrast, carbamazepine was devoid of any antiepieptogenic effects despite exhibiting marked anticonvulsant effects. Like valproate, phenobarbital exhibited both antiepileptogenic and anticonvulsant properties, but its antiepileptogenic properties were significantly less pronounced. The antiepileptogenic effects of valproate and phenobarbital strengthen the candidacy of these agents for the clinical studies needed to investigate pharmacological prevention of the development of epilepsy in high-risk groups.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1929206     DOI: 10.1002/ana.410290404

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  33 in total

Review 1.  Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research.

Authors:  Wolfgang Löscher; Claudia Brandt
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

2.  Results of phase 2 safety and feasibility study of treatment with levetiracetam for prevention of posttraumatic epilepsy.

Authors:  Pavel Klein; Daniel Herr; Phillip L Pearl; JoAnne Natale; Zachary Levine; Claude Nogay; Fabian Sandoval; Stacey Trzcinski; Shireen M Atabaki; Tammy Tsuchida; John van den Anker; Steven J Soldin; Jianping He; Robert McCarter
Journal:  Arch Neurol       Date:  2012-10

3.  Results of phase II pharmacokinetic study of levetiracetam for prevention of post-traumatic epilepsy.

Authors:  Pavel Klein; Daniel Herr; Phillip L Pearl; JoAnne Natale; Zachary Levine; Claude Nogay; Fabian Sandoval; Stacey Trzcinsky; Shireen M Atabaki; Tammy Tsuchida; John van den Anker; Steven J Soldin; Jianping He; Robert McCarter
Journal:  Epilepsy Behav       Date:  2012-07-07       Impact factor: 2.937

4.  Conventional anticonvulsant drugs in the guinea-pig kindling model of partial seizures: effects of repeated administration.

Authors:  Trevor H Gilbert; G Campbell Teskey
Journal:  Exp Brain Res       Date:  2007-01-26       Impact factor: 1.972

Review 5.  Disease modification in epilepsy: from animal models to clinical applications.

Authors:  Melissa L Barker-Haliski; Dan Friedman; Jacqueline A French; H Steve White
Journal:  Drugs       Date:  2015-05       Impact factor: 9.546

Review 6.  Epigenetic interventions for epileptogenesis: A new frontier for curing epilepsy.

Authors:  Iyan Younus; Doodipala Samba Reddy
Journal:  Pharmacol Ther       Date:  2017-03-06       Impact factor: 12.310

7.  Carbamazepine, but not valproate, displays pharmacoresistance in lamotrigine-resistant amygdala kindled rats.

Authors:  Ajay K Srivastava; H Steve White
Journal:  Epilepsy Res       Date:  2012-11-14       Impact factor: 3.045

8.  Ketogenic diet prevents epileptogenesis and disease progression in adult mice and rats.

Authors:  Theresa A Lusardi; Kiran K Akula; Shayla Q Coffman; David N Ruskin; Susan A Masino; Detlev Boison
Journal:  Neuropharmacology       Date:  2015-08-06       Impact factor: 5.250

Review 9.  Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy.

Authors:  Wolfgang Löscher
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

10.  Review of levetiracetam, with a focus on the extended release formulation, as adjuvant therapy in controlling partial-onset seizures.

Authors:  Carol M Ulloa; Allen Towfigh; Joseph Safdieh
Journal:  Neuropsychiatr Dis Treat       Date:  2009-09-15       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.